Singapore markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3100-0.0100 (-0.76%)
As of 01:18PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-32,485
-32,485
-32,947
376
-18,210
Depreciation & amortisation
67
67
145
178
180
Stock-based compensation
4,202
4,202
4,884
5,054
3,600
Change in working capital
720
720
11,236
-15,343
1,122
Accounts receivable
-220
-220
10,420
-10,869
1,893
Other working capital
-19,912
-19,912
-13,611
-10,733
-13,175
Other non-cash items
9,361
9,361
3,284
-
188
Net cash provided by operating activities
-18,135
-18,135
-13,365
-10,733
-13,120
Cash flows from investing activities
Investments in property, plant and equipment
-1,777
-1,777
-246
-
-55
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
0
Net cash used for investing activities
-1,777
-1,777
-246
0
-55
Cash flows from financing activities
Debt repayment
-
-
0
0
-5,340
Common stock issued
1,666
1,666
566
23,283
11,958
Other financing activities
10,319
-1,350
30,638
-
-
Net cash used provided by (used for) financing activities
414
414
31,333
23,782
7,867
Net change in cash
-19,498
-19,498
17,722
13,049
-5,308
Cash at beginning of period
48,418
48,418
30,696
17,647
22,955
Cash at end of period
28,920
28,920
48,418
30,696
17,647
Free cash flow
Operating cash flow
-18,135
-18,135
-13,365
-10,733
-13,120
Capital expenditure
-1,777
-1,777
-246
-
-55
Free cash flow
-19,912
-19,912
-13,611
-10,733
-13,175